I believe that news out of the conference coupled with further developments related to MANF will start the share price moving higher through the up-listing in 4Q2014.
I'm anxious to find out who the partner will be for LymPro in the U.S. I expect the company to have three or four partners spanning the globe.
If you have any funds available now is a great time to start adding shares.
Jason Napadano will be writing a new SeekingAlpha article after the conference.
Gerald's plan is coming together. Right management team with the right products at the right time.